These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 32497604)

  • 1. 2-[
    Manafi-Farid R; Karamzade-Ziarati N; Vali R; Mottaghy FM; Beheshti M
    Methods; 2021 Apr; 188():84-97. PubMed ID: 32497604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lung cancers: staging and response, CT,
    Owens C; Hindocha S; Lee R; Millard T; Sharma B
    Br J Radiol; 2023 Aug; 96(1148):20220339. PubMed ID: 37097296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [
    Manafi-Farid R; Askari E; Shiri I; Pirich C; Asadi M; Khateri M; Zaidi H; Beheshti M
    Semin Nucl Med; 2022 Nov; 52(6):759-780. PubMed ID: 35717201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graph Neural Network Model for Prediction of Non-Small Cell Lung Cancer Lymph Node Metastasis Using Protein-Protein Interaction Network and
    Ju H; Kim K; Kim BI; Woo SK
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2'-deoxy-2'-[18F] fluoro-D-glucose-PET/CT scans to predict survival early during treatment of locally advanced non-small cell lung cancer (NSCLC).
    Fledelius J; Khalil AA; Hjorthaug K; Frøkiaer J
    J Med Imaging Radiat Oncol; 2016 Apr; 60(2):231-8. PubMed ID: 26678718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can alternative PET reconstruction schemes improve the prognostic value of radiomic features in non-small cell lung cancer?
    Tankyevych O; Tixier F; Antonorsi N; Filali Razzouki A; Mondon R; Pinto-Leite T; Visvikis D; Hatt M; Cheze Le Rest C
    Methods; 2021 Apr; 188():73-83. PubMed ID: 33197567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early response evaluation using primary tumor and nodal imaging features to predict progression-free survival of locally advanced non-small cell lung cancer.
    Zhang N; Liang R; Gensheimer MF; Guo M; Zhu H; Yu J; Diehn M; Loo BW; Li R; Wu J
    Theranostics; 2020; 10(25):11707-11718. PubMed ID: 33052242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging features and prognostic value of
    Xu T; Zhang X; Zhang S; Liu C; Fu W; Zeng C; Chen Y
    BMC Cancer; 2020 Jun; 20(1):596. PubMed ID: 32586285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET/CT radiomics in breast cancer: Mind the step.
    Sollini M; Cozzi L; Ninatti G; Antunovic L; Cavinato L; Chiti A; Kirienko M
    Methods; 2021 Apr; 188():122-132. PubMed ID: 31978538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the diagnostic efficacy of
    Niyonkuru A; Chen X; Bakari KH; Wimalarathne DN; Bouhari A; Arnous MMR; Lan X
    Cancer Med; 2020 Feb; 9(3):931-942. PubMed ID: 31837121
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Sibille L; Seifert R; Avramovic N; Vehren T; Spottiswoode B; Zuehlsdorff S; Schäfers M
    Radiology; 2020 Feb; 294(2):445-452. PubMed ID: 31821122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of
    Delgado Bolton RC; Calapaquí-Terán AK; Giammarile F; Rubello D
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(4):229-233. PubMed ID: 31202725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Present and future roles of FDG-PET/CT imaging in the management of lung cancer.
    Kitajima K; Doi H; Kanda T; Yamane T; Tsujikawa T; Kaida H; Tamaki Y; Kuribayashi K
    Jpn J Radiol; 2016 Jun; 34(6):387-99. PubMed ID: 27121156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential feature exploration and model development based on 18F-FDG PET/CT images for differentiating benign and malignant lung lesions.
    Zhang R; Zhu L; Cai Z; Jiang W; Li J; Yang C; Yu C; Jiang B; Wang W; Xu W; Chai X; Zhang X; Tang Y
    Eur J Radiol; 2019 Dec; 121():108735. PubMed ID: 31733432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT radiomics analysis of lung cancers: Differentiation of squamous cell carcinoma from adenocarcinoma, a correlative study with FDG uptake.
    Tomori Y; Yamashiro T; Tomita H; Tsubakimoto M; Ishigami K; Atsumi E; Murayama S
    Eur J Radiol; 2020 Jul; 128():109032. PubMed ID: 32361604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study.
    Carvalho S; Leijenaar RTH; Troost EGC; van Timmeren JE; Oberije C; van Elmpt W; de Geus-Oei LF; Bussink J; Lambin P
    PLoS One; 2018; 13(3):e0192859. PubMed ID: 29494598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-treatment
    Ahn HK; Lee H; Kim SG; Hyun SH
    Clin Radiol; 2019 Jun; 74(6):467-473. PubMed ID: 30898382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep segmentation networks predict survival of non-small cell lung cancer.
    Baek S; He Y; Allen BG; Buatti JM; Smith BJ; Tong L; Sun Z; Wu J; Diehn M; Loo BW; Plichta KA; Seyedin SN; Gannon M; Cabel KR; Kim Y; Wu X
    Sci Rep; 2019 Nov; 9(1):17286. PubMed ID: 31754135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.
    Garcia-Velloso MJ; Bastarrika G; de-Torres JP; Lozano MD; Sanchez-Salcedo P; Sancho L; Nuñez-Cordoba JM; Campo A; Alcaide AB; Torre W; Richter JA; Zulueta JJ
    Lung Cancer; 2016 Jul; 97():81-6. PubMed ID: 27237032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.